2/12/2021 1:33:06 PM - Gapped down today testing its 50 DMA line ($132) which defines near-term support. Reported Dec &#39;20 quarterly earnings +50% on +19% sales revenues versus the year ago period. Quarterly earnings comparisons have been above the +25% minimum guideline (C criteria).  After years of losses it produced profitable results in FY &#39;17, &#39;18, and &#39;19. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.<br><hr>10/30/2020 12:36:32 PM - It wedged to new highs then stalled since last noted in the 9/04/20 mid-day report. Consolidating above prior highs in the $94 area and above its 50 DMA line ($89.18) which defines near-term support. Reported Sep &#39;20 quarterly earnings +108% on +21% sales revenues versus the year ago period. Quarterly earnings comparisons have been above the +25% minimum guideline (C criteria).  After years of losses it produced profitable results in FY &#39;17, &#39;18, and &#39;19. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.<br><hr>9/4/2020 12:03:36 PM - Still faces resistance due to overhead supply up to the $94 level. Undercutting its 50 DMA line ($83.66) with today&#39;s 2nd consecutive volume-driven loss. Noted in prior mid-day reports - <i>&quot;Reported Jun &#39;20 quarterly earnings +100% on +20% sales revenues versus the year ago period. Quarterly earnings comparisons have been above the +25% minimum guideline (C criteria).  After years of losses it produced profitable results in FY &#39;17, &#39;18, and &#39;19. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.&quot;</i><br><hr>8/31/2020 12:41:38 PM - Still faces resistance due to overhead supply up to the $94 level.  Rebounded above its 50 DMA line ($83.25) toward its all-time high with a big volume-driven gain on when noted in the 8/27/20 mid-day report - <i>&quot;Reported Jun &#39;20 quarterly earnings +100% on +20% sales revenues versus the year ago period. Quarterly earnings comparisons have been above the +25% minimum guideline (C criteria).  After years of losses it produced profitable results in FY &#39;17, &#39;18, and &#39;19. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.&quot;</i><br><hr>8/28/2020 12:06:51 PM - Still faces resistance due to overhead supply up to the $94 level.  Rebounded above its 50 DMA line ($83) toward its all-time high with a big volume-driven gain on the prior session when noted in the mid-day report - <i>&quot;Reported Jun &#39;20 quarterly earnings +100% on +20% sales revenues versus the year ago period. Quarterly earnings comparisons have been above the +25% minimum guideline (C criteria).  After years of losses it produced profitable results in FY &#39;17, &#39;18, and &#39;19. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.&quot;</i><br><hr>8/27/2020 11:50:13 AM - Rebounding above its 50 DMA line ($83) toward its all-time high with today&#39;s big volume-driven gain. Reported Jun &#39;20 quarterly earnings +100% on +20% sales revenues versus the year ago period. Quarterly earnings comparisons have been above the +25% minimum guideline (C criteria).  After years of losses it produced profitable results in FY &#39;17, &#39;18, and &#39;19. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.<br><hr>8/7/2020 12:36:23 PM - Very extended from any sound base and pulling back abruptly today, undercutting its 50 DMA line ($83.07), retreating from its all-time high hit this week. Reported Jun &#39;20 quarterly earnings +100% on +20% sales revenues versus the year ago period. Quarterly earnings comparisons have been above the +25% minimum guideline (C criteria).  After years of losses it produced profitable results in FY &#39;17, &#39;18, and &#39;19. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.<br><hr>8/9/2019 1:17:48 PM - Pulling back after recently challenging its all-time high. Limited earnings history (C and A criteria) is a concern with regard to the fact-based investment system.<br><hr>